Systemic brain derived neurotrophic factor but not intestinal barrier integrity is associated with cognitive decline and incident Alzheimer’s disease
Open Access
- 4 March 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3), e0240342
- https://doi.org/10.1371/journal.pone.0240342
Abstract
The inflammatory hypothesis posits that sustained neuroinflammation is sufficient to induce neurodegeneration and the development of Alzheimer’s disease (AD) and Alzheimer’s dementia. One potential source of inflammation is the intestine which harbors pro-inflammatory microorganisms capable of promoting neuroinflammation. Systemic inflammation is robustly associated with neuroinflammation as well as low levels of brain derived neurotrophic factor (BDNF) in the systemic circulation and brain. Thus, in this pilot study, we tested the hypothesis that intestinal barrier dysfunction precedes risk of death, incident AD dementia and MCI, cognitive impairment and neuropathology. Serum BDNF was associated with changes in global cognition, working memory, and perceptual speed but not risk of death, incident AD dementia, incident MCI, or neuropathology. Neither of the markers of intestinal barrier integrity examined, including lipopolysaccharide binding protein (LBP) nor intestinal fatty acid binding protein (IFABP), were associated with risk of death, incident AD dementia, incident mild cognitive impairment (MCI), change in cognition (global or domains), or neuropathology. Taken together, the data in this pilot study suggest that intestinal barrier dysfunction does not precede diagnosis of AD or MCI, changes in cognition, or brain pathology. However, since MCI and AD are related to global cognition, the findings with BDNF and the contiguous cognitive measures suggest low power with the trichotomous cognitive status measures. Future studies with larger sample sizes are necessary to further investigate the results from this pilot study.Funding Information
- National Institutes of Health (AG056653)
- National Institutes of Health (AG010161)
- Philanthropy- Mrs. Ellen and Mr. Phillip Glass
This publication has 56 references indexed in Scilit:
- Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological DiseasesBioMed Research International, 2013
- Brain-Derived Neurotrophic Factor Is Associated with Age-Related Decline in Hippocampal VolumeJournal of Neuroscience, 2010
- Physical Frailty Is Associated with Incident Mild Cognitive Impairment in Community‐Based Older PersonsJournal of the American Geriatrics Society, 2010
- Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohortNeurology, 2009
- Decreased Serum Brain-Derived Neurotrophic Factor Levels in Elderly Korean with DementiaPsychiatry Investigation, 2009
- Protective effects of NSAIDs on the development of Alzheimer diseaseNeurology, 2008
- Structural organization of the tight junctionsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- BDNF is essential to promote persistence of long-term memory storageProceedings of the National Academy of Sciences of the United States of America, 2008
- Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4European Journal of Neuroscience, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984